Combined vaccine against Hemorrhagic Disease and Myxomatosis
Your message has been sent
Vaccine contains two components with an equal amount of doses:
Suspension of inactivated agent of rabbit Hemorrhagic Disease, strain BG-04 from 640 to 1280 HAU in one dose, as a solvent for freeze-dried tablet;
Freeze-dried tablet of vaccine virus of Myxomatosis, strain MAV/RK – 13/20 ≥ 104,0 EID50 in one dose.
Freeze-dried tablet and suspension.
Vaccine protects rabbits from Hemorrhagic Disease and Myxomatosis during 8-10 months, induces formation of protective antibodies in 7-14 days after vaccination.
Preventative immunization of rabbits against Hemorrhagic Disease and Myxomatosis.
Interaction with other preparations
Do not mix with other preparations, with components of other vaccines against rabbit disease and components of other batches of LAPIMUN GEMIX vaccine. Dehelmintization of rabbits is to be performed 2 weeks prior to or 2 weeks after vaccination.
Special precautions (during gestation period)
It is not recommended to vaccinate females 7 days before the parturition, because of "mechanical" abortions that may occur due to animals’ stresses.
Route of administration and dosage
After shaking, using a syringe, vaccine component in suspension form is transferred into the vial with freeze-dried component.
Multiplicity of the vaccination
Rabbits in non-endemic areas
At the age of 10 weeks
Subcutaneously, behind the shoulder blade
Rabbits at the threat of early infection
At the age of 4 weeks
Revaccination at the age of 4 months
Re-vaccination is carried out every 8 months.
18 months. Vaccine should be used within 3 hours after dissolving.
Store vaccine in dry, dark places, out of the reach of children, at +2 to +8° С. Do not freeze!